Polaris Venture Management Co. V, L.l.c.

Affiliations

  • Large Shareholder at Lyra Therapeutics Inc. (LYRA), 2020-05-06
  • Large Shareholder at Phreesia Inc. (PHR), 2019-12-18
  • Large Shareholder at Cardlytics Inc. (CDLX), 2019-07-17
  • Large Shareholder at Pulmatrix Inc. (PULM), 2018-04-06
  • Large Shareholder at Arsanis Inc. (ASNS), 2017-11-20
  • Large Shareholder at Kala Pharmaceuticals Inc. (KALA), 2017-07-19
  • Large Shareholder at Selecta Biosciences Inc (SELB), 2016-06-29
  • Large Shareholder at T2 Biosystems Inc. (TTOO), 2015-08-07
  • Large Shareholder at Genocea Biosciences Inc. (GNCA), 2015-06-19
  • Large Shareholder at Atyr Pharma Inc (LIFE), 2015-05-15
  • Large Shareholder at Ocular Therapeutix Inc (OCUL), 2015-02-04
  • Large Shareholder at Trevena Inc (TRVN), 2014-08-18
  • Large Shareholder at Cerulean Pharma Inc. (CERU), 2014-04-16
  • Large Shareholder at Fate Therapeutics Inc (FATE), 2013-10-07
  • Large Shareholder at Bind Therapeutics Inc (BIND), 2013-09-27
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LYRA $16.00 413 Large Shareholder 7,274 2020-05-05 Filing
LYRA $16.00 603 Large Shareholder 10,618 2020-05-05 Filing
LYRA $16.00 1,176 Large Shareholder 20,701 2020-05-05 Filing
LYRA $16.00 60,308 Large Shareholder 1,062,259 2020-05-05 Filing
ASNS $10.00 4,825 Large Shareholder 18,031 2017-11-20 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LYRA $16.00 64 Large Shareholder 6,861 2020-05-05 Filing
LYRA $16.00 94 Large Shareholder 10,015 2020-05-05 Filing
LYRA $16.00 182 Large Shareholder 19,525 2020-05-05 Filing
LYRA $16.00 9,334 Large Shareholder 1,001,951 2020-05-05 Filing
PHR $24.48 3,446 Large Shareholder 31,015 2019-12-17 Filing